These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 24528042)
1. Expression of osteopontin in non-small cell lung cancer and correlative relation with microvascular density. Yu TT; Han ZG; Shan L; Tao J; Zhang T; Yuan SF; Shen HL Asian Pac J Cancer Prev; 2014; 15(1):29-32. PubMed ID: 24528042 [TBL] [Abstract][Full Text] [Related]
2. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance]. Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878 [TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer. Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318 [TBL] [Abstract][Full Text] [Related]
4. Osteopontin expression is associated with platinum-based chemotherapy response and prognosis of patients with advanced non small cell lung cancer. Zhang T; Zhang DM; Zhao D; Hou XM; Yang TN J BUON; 2014; 19(3):742-8. PubMed ID: 25261661 [TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological value of osteopontin expression in non-small cell lung cancer: a meta-analysis and systematic review. Song Y; Li H; Jiang Q; Wu L Biomarkers; 2024 Mar; 29(2):105-113. PubMed ID: 38376506 [TBL] [Abstract][Full Text] [Related]
6. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer. Chang YS; Kim HJ; Chang J; Ahn CM; Kim SK; Kim SK Lung Cancer; 2007 Sep; 57(3):373-80. PubMed ID: 17513004 [TBL] [Abstract][Full Text] [Related]
7. The prognostic value of osteopontin expression in non-small cell lung cancer: a meta-analysis. Zhang T; Zhang DM; Zhao D; Hou XM; Liu XJ; Ling XL; Ma SC J Mol Histol; 2014 Oct; 45(5):533-40. PubMed ID: 24816798 [TBL] [Abstract][Full Text] [Related]
8. [Expression of erythropoietin and erythropoietin receptor in non-small cell lung cancer and its correlation with microvessel density]. Han ZG; Yu TT; Shan L Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):605-8. PubMed ID: 23158995 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. Shijubo N; Uede T; Kon S; Maeda M; Segawa T; Imada A; Hirasawa M; Abe S Am J Respir Crit Care Med; 1999 Oct; 160(4):1269-73. PubMed ID: 10508818 [TBL] [Abstract][Full Text] [Related]
10. Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection. Yan CH; Lv M; Li H; Song X; Yan F; Cao S; Ren X J Cancer Res Clin Oncol; 2015 Aug; 141(8):1371-8. PubMed ID: 25555465 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of osteopontin, αvβ3 and Pim-1 associated with prognostically important clinicopathologic variables in non-small cell lung cancer. Jin Y; Tong DY; Chen JN; Feng ZY; Yang JY; Shao CK; Li JP PLoS One; 2012; 7(10):e48575. PubMed ID: 23119061 [TBL] [Abstract][Full Text] [Related]
12. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer. Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280 [TBL] [Abstract][Full Text] [Related]
13. [Protein and mRNA expression of osteopontin in lung cancer and clinical significance thereof]. Gui SY; Li HH; Zuo L; Zhou Q; Wu Q; Wang Y Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3219-23. PubMed ID: 18399118 [TBL] [Abstract][Full Text] [Related]
14. Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer. Ostheimer C; Bache M; Güttler A; Reese T; Vordermark D BMC Cancer; 2014 Nov; 14():858. PubMed ID: 25416631 [TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume. Ostheimer C; Evers C; Bache M; Reese T; Vordermark D Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706 [TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker. Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer. Boldrini L; Donati V; Dell'Omodarme M; Prati MC; Faviana P; Camacci T; Lucchi M; Mussi A; Santoro M; Basolo F; Fontanini G Br J Cancer; 2005 Aug; 93(4):453-7. PubMed ID: 16091764 [TBL] [Abstract][Full Text] [Related]
18. Osteopontin is associated with decreased apoptosis and αv integrin expression in lung adenocarcinoma. Štemberger C; Matušan-Ilijaš K; Avirović M; Bulat-Kardum L; Ivančić A; Jonjić N; Lučin K Acta Histochem; 2014 Jan; 116(1):222-9. PubMed ID: 23992637 [TBL] [Abstract][Full Text] [Related]
19. Osteopontin is a prognostic biomarker in non-small cell lung cancer. Kongsgaard A; Boye K; Oijordsbakken M; Lund-Iversen M; Halvorsen AR; Solberg SK; Berge G; Helland A; Brustugun OT; Mælandsmo GM BMC Cancer; 2013 Nov; 13():540. PubMed ID: 24215488 [TBL] [Abstract][Full Text] [Related]
20. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma]. Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]